Paul H Klingenstein's Net Worth

$2.31 Billion

Estimate Recalculated Feb 27, 2024 07:15PM EST

Who is Paul H Klingenstein?

Paul H Klingenstein has an estimated net worth of $2.31 Billion. This is based on reported shares across multiple companies, which include METROPCS COMMUNICATIONS INC, Anacor Pharmaceuticals, Inc., EnteroMedics Inc, Clovis Oncology, Inc., and Conatus Pharmaceuticals Inc.

SEC CIK

Paul H Klingenstein's CIK is 0000935463

Past Insider Trading and Trends

2010 was Paul H Klingenstein's most active year for acquiring shares with 18 total transactions. Paul H Klingenstein's most active month to acquire stocks was the month of October. 2007 was Paul H Klingenstein's most active year for disposing of shares, totalling 12 transactions. Paul H Klingenstein's most active month to dispose stocks was the month of October. 2011 saw Paul H Klingenstein paying a total of $5,190,783.00 for 1,358,665 shares, this is the most they've acquired in one year. In 2011 Paul H Klingenstein cashed out on 2,315,653 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

METROPCS COMMUNICATIONS INC (TMUS) Snapshot price: $161.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,818.47%
13.62M
14.37M
Apr 24
Form 3/A
0
0
Form 3
0
0
Form 3
0
0
No matching records found

Anacor Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 29
Form 4
0
0
Jun 6
Form 4
0
0
May 30
Form 4
0
0
May 25
Form 4
0
0
Mar 31
Form 4
1.81M
$5.00
1.81M
Nov 30
Form 3
0
0
No matching records found

EnteroMedics Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 8
Form 4
0
0
May 9
Form 4
0
0
May 5
Form 4
+142.71%
423.03K
719.46K
Dec 14
Form 4
0
0
Sep 30
Form 4
0
0
May 6
Form 4
0
0
May 5
Form 4
+255.94%
1.24M
$1.15
$1,422,679.95
1.72M
Feb 24
Form 4
+5.06%
92.2K
$4.50
$414,900.00
1.91M
May 29 - Jun 2
Form 4
+2.82%
50K
$4.50
$225,000.00
1.82M
May 23
Form 4
+5.98%
100K
$4.77
$477,100.00
1.77M
May 19 - May 20
Form 4
0
0
Mar 25
Form 4
+604.13%
1.51M
1.76M
Nov 20
Form 4
250K
$8.00
$2,000,000.00
250K
Nov 15
Form 3
0
0
No matching records found

Clovis Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 10
Form 4
0
0
Jun 4
Form 4
+77.28%
25.86K
$0.29
$7,499.98
59.33K
Jul 29
Form 4
0
0
Jun 6
Form 4
0
0
Oct 11
Form 4
0
0
Jun 8
Form 4
0
0
Jun 9
Form 4
0
0
Jun 11
Form 4
0
0
Jun 12
Form 4
0
0
Jun 13
Form 4
0
0
Jun 14
Form 4
1.3M
$13.00
1.3M
Nov 21
Form 3
0
0
No matching records found

Conatus Pharmaceuticals Inc (HSTO) Snapshot price: $0.34

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found